Cryoport, a major embryo shipping company, said on Friday that it was “pausing” its business in Alabama as it evaluated the state’s Supreme Court decision that declared frozen embryos created through in vitro fertilization to be children.
“Until the company has further clarity on the decision and what it means for Cryoport, clinics and intended parents, it is pausing all activity in Alabama until further notice,” read an email received by an Alabama fertility clinic and shared with The New York Times.
The Alabama court’s ruling has already significantly limited fertility treatment for patients in that state.
Three clinics have paused care as they evaluate what the ruling means for their patients and their own legal liability.
It found that clinics could be held liable for wrongful death claims, bringing new gravity to accidents that are not uncommon in fertility treatment.
Persons:
”, Cryoport
Organizations:
The New York Times
Locations:
Alabama, Mobile